HV
Clinical trials for HV explained in plain language.
Never miss a new study
Get alerted when new HV trials appear
Sign up with your email to follow new studies for HV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BW-41012 enters first human safety tests
Knowledge-focused Not yet recruitingThis early-phase trial will test the safety and tolerability of a single injection of BW-41012 in 40 healthy adults aged 18 to 65. Participants will be randomly assigned to receive either the drug or a placebo, and researchers will monitor for side effects and measure how the dru…
Matched conditions: HV
Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New drug BW-20805-2 put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a single dose of an experimental drug called BW-20805-2 in 24 healthy adults aged 18 to 60. The main goal is to check for side effects and see how the drug moves through the body. Participants receive one injection under the skin and are monitored for…
Matched conditions: HV
Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC